Rohitash Yadav

1.3k total citations · 1 hit paper
31 papers, 934 citations indexed

About

Rohitash Yadav is a scholar working on Organic Chemistry, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Rohitash Yadav has authored 31 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 12 papers in Computational Theory and Mathematics and 11 papers in Infectious Diseases. Recurrent topics in Rohitash Yadav's work include Computational Drug Discovery Methods (12 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Synthesis and biological activity (7 papers). Rohitash Yadav is often cited by papers focused on Computational Drug Discovery Methods (12 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Synthesis and biological activity (7 papers). Rohitash Yadav collaborates with scholars based in India, Türkiye and Saudi Arabia. Rohitash Yadav's co-authors include Puneet Dhamija, Shailendra Handu, Jitendra Kumar Chaudhary, Pankaj Kumar Chaudhary, İsmail Çeli̇k, Neeraj Jain, Ashish Kumar, Ambika Sharma, Y. Sheena Mary and Mohammed Imran and has published in prestigious journals such as Journal of Molecular Liquids, Biomedicine & Pharmacotherapy and Cells.

In The Last Decade

Rohitash Yadav

30 papers receiving 911 citations

Hit Papers

Role of Structural and Non-Structural Proteins and Therap... 2021 2026 2022 2024 2021 100 200 300

Peers

Rohitash Yadav
Rohitash Yadav
Citations per year, relative to Rohitash Yadav Rohitash Yadav (= 1×) peers Umesh Yadava

Countries citing papers authored by Rohitash Yadav

Since Specialization
Citations

This map shows the geographic impact of Rohitash Yadav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohitash Yadav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohitash Yadav more than expected).

Fields of papers citing papers by Rohitash Yadav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohitash Yadav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohitash Yadav. The network helps show where Rohitash Yadav may publish in the future.

Co-authorship network of co-authors of Rohitash Yadav

This figure shows the co-authorship network connecting the top 25 collaborators of Rohitash Yadav. A scholar is included among the top collaborators of Rohitash Yadav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohitash Yadav. Rohitash Yadav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yadav, Rohitash, et al.. (2024). Dostarlimab: Review on success story and clinical trials. Critical Reviews in Oncology/Hematology. 198. 104374–104374. 3 indexed citations
2.
Lakhera, Shradha, Meenakshi Rana, Kamal Devlal, İsmail Çeli̇k, & Rohitash Yadav. (2022). A comprehensive exploration of pharmacological properties, bioactivities and inhibitory potentiality of luteolin from Tridax procumbens as anticancer drug by in-silico approach. Structural Chemistry. 33(3). 703–719. 19 indexed citations
3.
Yadav, Rohitash, Uttam Kumar Nath, İsmail Çeli̇k, et al.. (2022). Identification and in-vitro analysis of potential proteasome inhibitors targeting PSMβ5 for multiple myeloma. Biomedicine & Pharmacotherapy. 157. 113963–113963. 9 indexed citations
4.
Khatabi, Khalil El, Reda El-Mernissi, Hafiz Muzzammel Rehman, et al.. (2022). Rational design of novel potential EGFR inhibitors by 3D-QSAR, molecular docking, molecular dynamics simulation, and pharmacokinetics studies. Chemical Data Collections. 39. 100851–100851. 14 indexed citations
5.
Chaudhary, Jitendra Kumar, Rohitash Yadav, Pankaj Kumar Chaudhary, et al.. (2021). Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Cells. 10(11). 2949–2949. 25 indexed citations
6.
7.
Yadav, Rohitash, et al.. (2021). MD, DFT Investigations and Inhibition of the Novel SARS- CoV-2 Mainprotease in Three Cocrystals of Hydrochloro- thiazide. Analytical Chemistry Letters. 11(4). 450–468. 3 indexed citations
8.
Mary, Y. Sheena, Y. Shyma Mary, Stevan Armaković, et al.. (2021). Investigation of reactive properties, adsorption on fullerene, DFT, molecular dynamics simulation of an anthracene derivative targeting dihydrofolate reductase and human dUTPase. Journal of Biomolecular Structure and Dynamics. 40(21). 10952–10961. 12 indexed citations
9.
Mary, Y. Sheena, Y. Shyma Mary, Stevan Armaković, et al.. (2021). Investigation of reactive properties of an antiviral azatricyclo derivative–KDFT, MD and docking simulations. Journal of Molecular Structure. 1230. 129937–129937. 9 indexed citations
11.
Yadav, Rohitash, İsmail Çeli̇k, Y. Sheena Mary, et al.. (2021). Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2. Journal of Molecular Liquids. 342. 116942–116942. 45 indexed citations
12.
Al‐Otaibi, Jamelah S., Y. Sheena Mary, Y. Shyma Mary, et al.. (2021). Adsorption properties of dacarbazine with graphene/fullerene/metal nanocages – Reactivity, spectroscopic and SERS analysis. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 268. 120677–120677. 37 indexed citations
13.
Mary, Y. Sheena, Y. Shyma Mary, Stevan Armaković, et al.. (2021). Stability and reactivity study of bio-molecules brucine and colchicine towards electrophile and nucleophile attacks: Insight from DFT and MD simulations. Journal of Molecular Liquids. 335. 116192–116192. 56 indexed citations
14.
Al‐Otaibi, Jamelah S., et al.. (2021). Structural and reactivity studies of pravadoline –An ionic liquid, with reference to its wavefunction-relative properties using DFT and MD simulation. Journal of Molecular Structure. 1245. 131074–131074. 23 indexed citations
15.
Mary, Y. Sheena, Y. Shyma Mary, Özlem Temiz‐Arpacı, Rohitash Yadav, & İsmail Çeli̇k. (2021). DFT, docking, MD simulation, and vibrational spectra with SERS analysis of a benzoxazole derivative: an anti-cancerous drug. Chemical Papers. 75(8). 4269–4284. 5 indexed citations
16.
Çevik, Ulviye Acar, İsmail Çeli̇k, Renjith Raveendran Pillai, et al.. (2021). Synthesis, molecular modeling, quantum mechanical calculations and ADME estimation studies of benzimidazole-oxadiazole derivatives as potent antifungal agents. Journal of Molecular Structure. 1252. 132095–132095. 35 indexed citations
17.
18.
Rolta, Rajan, Rohitash Yadav, Deeksha Salaria, et al.. (2020). In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly. Journal of Biomolecular Structure and Dynamics. 39(18). 7017–7034. 92 indexed citations
19.
Yadav, Rohitash, Ripu Daman Parihar, Puneet Dhamija, et al.. (2020). Docking of FDA Approved Drugs Targeting NSP-16, N-Protein and Main Protease of SARS-CoV-2 as Dual Inhibitors. Biointerface Research in Applied Chemistry. 11(3). 9848–9861. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026